Precipio - PRPO Stock Forecast, Price & News

Precipio's stock was trading at $1.58 at the start of the year. Since then, PRPO shares have decreased by 3.8% and is now trading at $1.52.
View the best growth stocks for 2022 here.

Precipio saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 90,200 shares, a decline of 29.8% from the July 15th total of 128,500 shares. Based on an average trading volume of 278,800 shares, the short-interest ratio is presently 0.3 days.
View Precipio's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our PRPO earnings forecast.

Precipio, Inc. (NASDAQ:PRPO) issued its earnings results on Thursday, August, 23rd. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $1.93 by $2.08. The biotechnology company had revenue of $0.82 million for the quarter. Precipio had a negative net margin of 123.12% and a negative trailing twelve-month return on equity of 46.63%.

Precipio's stock reverse split on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Co-Diagnostics (CODX), Inpixon (INPX) and Jaguar Health (JAGX).

Precipio trades on the NASDAQ under the ticker symbol "PRPO."

Precipio's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Great Valley Advisor Group Inc. (0.15%). Insiders that own company stock include Ahmed Zaki Sabet, David Seth Cohen and Ilan Danieli.
View institutional ownership trends.

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PRPO stock can currently be purchased for approximately $1.52.

Precipio (NASDAQ:PRPO) has a market capitalization of $34.52 million and generates $8.85 million in revenue each year. The biotechnology company earns $-8,530,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.

Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The official website for the company is www.precipiodx.com. The biotechnology company can be reached via phone at (203) 787-7888, via email at investors@precipiodx.com, or via fax at 402-452-5401.